Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Endoscopic Fluorescence-Guided Resection Increases Radicality in Glioblastoma Surgery.

Bettag C, Hussein A, Behme D, Maragkou T, Rohde V, Mielke D.

Oper Neurosurg (Hagerstown). 2020 Jan 1;18(1):41-46. doi: 10.1093/ons/opz082.

PMID:
31058980
2.

Endoscopic-assisted visualization of 5-aminolevulinic acid-induced fluorescence in malignant glioma surgery: a technical note.

Rapp M, Kamp M, Steiger HJ, Sabel M.

World Neurosurg. 2014 Jul-Aug;82(1-2):e277-9. doi: 10.1016/j.wneu.2013.07.002. Epub 2013 Jul 16.

PMID:
23871813
3.

Combining 5-Aminolevulinic Acid Fluorescence and Intraoperative Magnetic Resonance Imaging in Glioblastoma Surgery: A Histology-Based Evaluation.

Hauser SB, Kockro RA, Actor B, Sarnthein J, Bernays RL.

Neurosurgery. 2016 Apr;78(4):475-83. doi: 10.1227/NEU.0000000000001035.

4.

Aggressive resection at the infiltrative margins of glioblastoma facilitated by intraoperative fluorescein guidance.

Neira JA, Ung TH, Sims JS, Malone HR, Chow DS, Samanamud JL, Zanazzi GJ, Guo X, Bowden SG, Zhao B, Sheth SA, McKhann GM 2nd, Sisti MB, Canoll P, D'Amico RS, Bruce JN.

J Neurosurg. 2017 Jul;127(1):111-122. doi: 10.3171/2016.7.JNS16232. Epub 2016 Oct 7.

PMID:
27715437
5.

Systematic histopathological analysis of different 5-aminolevulinic acid-induced fluorescence levels in newly diagnosed glioblastomas.

Kiesel B, Mischkulnig M, Woehrer A, Martinez-Moreno M, Millesi M, Mallouhi A, Czech T, Preusser M, Hainfellner JA, Wolfsberger S, Knosp E, Widhalm G.

J Neurosurg. 2018 Aug;129(2):341-353. doi: 10.3171/2017.4.JNS162991. Epub 2017 Oct 27.

PMID:
29076783
6.
7.

Prognostic value of residual fluorescent tissue in glioblastoma patients after gross total resection in 5-aminolevulinic Acid-guided surgery.

Aldave G, Tejada S, Pay E, Marigil M, Bejarano B, Idoate MA, Díez-Valle R.

Neurosurgery. 2013 Jun;72(6):915-20; discussion 920-1. doi: 10.1227/NEU.0b013e31828c3974.

PMID:
23685503
8.

Surgery guided by 5-aminolevulinic fluorescence in glioblastoma: volumetric analysis of extent of resection in single-center experience.

Díez Valle R, Tejada Solis S, Idoate Gastearena MA, García de Eulate R, Domínguez Echávarri P, Aristu Mendiroz J.

J Neurooncol. 2011 Mar;102(1):105-13. doi: 10.1007/s11060-010-0296-4. Epub 2010 Jul 6.

PMID:
20607351
9.

5-ALA complete resections go beyond MR contrast enhancement: shift corrected volumetric analysis of the extent of resection in surgery for glioblastoma.

Schucht P, Knittel S, Slotboom J, Seidel K, Murek M, Jilch A, Raabe A, Beck J.

Acta Neurochir (Wien). 2014 Feb;156(2):305-12; discussion 312. doi: 10.1007/s00701-013-1906-7. Epub 2013 Oct 25.

PMID:
24449075
10.

5-Aminolevulinic Acid Fluorescence-Guided Resection of 18F-FET-PET Positive Tumor Beyond Gadolinium Enhancing Tumor Improves Survival in Glioblastoma.

Müther M, Koch R, Weckesser M, Sporns P, Schwindt W, Stummer W.

Neurosurgery. 2019 Dec 1;85(6):E1020-E1029. doi: 10.1093/neuros/nyz199.

11.

Tumor detection with 5-aminolevulinic acid fluorescence and Gd-DTPA-enhanced intraoperative MRI at the border of contrast-enhancing lesions: a prospective study based on histopathological assessment.

Coburger J, Engelke J, Scheuerle A, Thal DR, Hlavac M, Wirtz CR, König R.

Neurosurg Focus. 2014 Feb;36(2):E3. doi: 10.3171/2013.11.FOCUS13463.

PMID:
24484256
12.

Resection of malignant brain tumors in eloquent cortical areas: a new multimodal approach combining 5-aminolevulinic acid and intraoperative monitoring.

Feigl GC, Ritz R, Moraes M, Klein J, Ramina K, Gharabaghi A, Krischek B, Danz S, Bornemann A, Liebsch M, Tatagiba MS.

J Neurosurg. 2010 Aug;113(2):352-7. doi: 10.3171/2009.10.JNS09447.

PMID:
19911888
13.

Characterizing the heterogeneity in 5-aminolevulinic acid-induced fluorescence in glioblastoma.

Almiron Bonnin DA, Havrda MC, Lee MC, Evans L, Ran C, Qian DC, Harrington LX, Valdes PA, Cheng C, Amos CI, Harris BT, Paulsen KD, Roberts DW, Israel MA.

J Neurosurg. 2019 May 24:1-9. doi: 10.3171/2019.2.JNS183128. [Epub ahead of print]

PMID:
31125970
14.

Image guided surgery for the resection of brain tumours.

Barone DG, Lawrie TA, Hart MG.

Cochrane Database Syst Rev. 2014 Jan 28;(1):CD009685. doi: 10.1002/14651858.CD009685.pub2. Review.

15.

Intraoperative imaging technology to maximise extent of resection for glioma.

Jenkinson MD, Barone DG, Bryant A, Vale L, Bulbeck H, Lawrie TA, Hart MG, Watts C.

Cochrane Database Syst Rev. 2018 Jan 22;1:CD012788. doi: 10.1002/14651858.CD012788.pub2. Review.

16.

Novel Wavelength-Specific Blue Light-Emitting Headlamp for 5-Aminolevulinic Acid Fluorescence-Guided Resection of Glioblastoma.

Woo PYM, Law M, Gai X, Ng BCF, Ko NMW, Wong HT, Chan KY.

World Neurosurg. 2019 Nov;131:220-226. doi: 10.1016/j.wneu.2019.08.025. Epub 2019 Aug 12.

PMID:
31415891
17.

Accuracy of High-Field Intraoperative MRI in the Detectability of Residual Tumor in Glioma Grade IV Resections.

Heßelmann V, Mager AK, Goetz C, Detsch O, Theisgen HK, Friese M, Schwindt W, Gottschalk J, Kremer P.

Rofo. 2017 Jun;189(6):519-526. doi: 10.1055/s-0043-106189. Epub 2017 Jun 7.

18.

Fluorescence-guided surgery in high grade gliomas using an exoscope system.

Belloch JP, Rovira V, Llácer JL, Riesgo PA, Cremades A.

Acta Neurochir (Wien). 2014 Apr;156(4):653-60. doi: 10.1007/s00701-013-1976-6. Epub 2014 Jan 28.

PMID:
24468884
19.

Intraoperative tissue fluorescence using 5-aminolevolinic acid (5-ALA) is more sensitive than contrast MRI or amino acid positron emission tomography ((18)F-FET PET) in glioblastoma surgery.

Roessler K, Becherer A, Donat M, Cejna M, Zachenhofer I.

Neurol Res. 2012 Apr;34(3):314-7. doi: 10.1179/1743132811Y.0000000078. Epub 2012 Mar 1.

PMID:
22449387
20.

5-ALA-induced fluorescence behavior of reactive tissue changes following glioblastoma treatment with radiation and chemotherapy.

Kamp MA, Felsberg J, Sadat H, Kuzibaev J, Steiger HJ, Rapp M, Reifenberger G, Dibué M, Sabel M.

Acta Neurochir (Wien). 2015 Feb;157(2):207-13; discussion 213-4. doi: 10.1007/s00701-014-2313-4. Epub 2014 Dec 30.

PMID:
25547719

Supplemental Content

Support Center